Southern XP IP Pty Ltd
🇦🇺Australia
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
99
TGA:99
Drug Approvals
CYCLIZINE ANS cyclizine lactate 50 mg/1 mL solution for injection ampoule (413623)
- Product Name
- CYCLIZINE ANS cyclizine lactate 50 mg/1 mL solution for injection ampoule
- Approval Date
- Jan 2, 2025
TGA
CYCLIZINE SXP cyclizine lactate 50 mg/1 mL solution for injection ampoule (413625)
- Product Name
- CYCLIZINE SXP cyclizine lactate 50 mg/1 mL solution for injection ampoule
- Approval Date
- Jan 2, 2025
TGA
FULVESTRANT ANS fulvestrant 250 mg/5 mL solution for injection pre-filled syringe (427478)
- Product Name
- FULVESTRANT ANS fulvestrant 250 mg/5 mL solution for injection pre-filled syringe
- Approval Date
- Jan 2, 2025
TGA
FULVESTRANT LWS fulvestrant 250 mg/5 mL solution for injection pre-filled syringe (427479)
- Product Name
- FULVESTRANT LWS fulvestrant 250 mg/5 mL solution for injection pre-filled syringe
- Approval Date
- Jan 2, 2025
TGA
FULVESTRANT SXP fulvestrant 250 mg/5 mL solution for injection pre-filled syringe (427480)
- Product Name
- FULVESTRANT SXP fulvestrant 250 mg/5 mL solution for injection pre-filled syringe
- Approval Date
- Jan 2, 2025
TGA
CYCLIZINE HMH cyclizine lactate 50 mg/1 mL solution for injection ampoule (413624)
- Product Name
- CYCLIZINE HMH cyclizine lactate 50 mg/1 mL solution for injection ampoule
- Approval Date
- Jan 2, 2025
TGA
TERLIPRESSIN HMH terlipressin (as acetate) 0.85 mg/8.5mL solution for injection vial (394191)
- Product Name
- TERLIPRESSIN HMH terlipressin (as acetate) 0.85 mg/8.5mL solution for injection vial
- Approval Date
- Sep 30, 2024
TGA
TERLIPRESSIN ANS terlipressin (as acetate) 0.85 mg/8.5mL solution for injection vial (394192)
- Product Name
- TERLIPRESSIN ANS terlipressin (as acetate) 0.85 mg/8.5mL solution for injection vial
- Approval Date
- Sep 30, 2024
TGA
TERLIPRESSIN SXP terlipressin (as acetate) 0.85 mg/8.5mL solution for injection vial (394190)
- Product Name
- TERLIPRESSIN SXP terlipressin (as acetate) 0.85 mg/8.5mL solution for injection vial
- Approval Date
- Sep 30, 2024
TGA
VALPROATE LWS sodium valproate 300 mg/3 mL solution for injection vial (422116)
- Product Name
- VALPROATE LWS sodium valproate 300 mg/3 mL solution for injection vial
- Approval Date
- Aug 19, 2024
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found